{"ticker": {"uuid": "acc77fe3-1c93-46f3-a9a1-1d4d33093d4e", "symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Takeda Stock - analyst focus on pipeline and earnings outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOSklscmUxY3JSV1lQb1docmxYSWZleFl2OHRnWXpQdzNvWGRUZVZuVzhNSG8tV3J6LVpqU3l0ZWN5SkUwdFBWOXBIUXVnQ2k4cklhTzNlTHU2a3pJYTItYnZQYVltX1ozSWNmS0dYRzVqLTlscV9jTEFCMDJKYlY2TDRHU0ZSdlRzbkhQdC0zM2pEV0NndEpxbEVUQjNhUG9PRElzWEhYMmYyV0JYaVFKTWk1eUY5OXdNOGc?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-17T19:04:03+00:00", "published_display": "17 Jun 2026 19:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (TSE:4502) Unveils Phase 3 Wins In Narcolepsy And Psoriasis", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOOFZHOVZPOG1yeU9UTFdIWHFHYVhxcTkyZnVPem02T0QzZjNqZ19NcXhEQ2hQY0M4N2pieHhBbkxxY0c0Y2JhQWd4ODNSZ3JYanluNXBDM2RTNTRrRjVwZjZiXzd0STVMN0xueFlyTjJoa3FoYzRNSVloaFJlR2htaXRWSjNJWEZFc29wUmhWSFBubnly?oc=5", "source_name": "Market source", "published_at": "2026-06-16T18:13:39+00:00", "published_display": "16 Jun 2026 18:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Co Ltd (TSE:4502) Stock Price, Trades & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9GaWtTdlJmYTdXTDhCTUpta2NoNWhCVXFWNmRhUGNSbVJacjhNSzlIZkc0dzlWU2VlQnUtNWNKa1IyaTJ2X3gzbHpENmJnM0lJWWE1NTVnNDVzVThE?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-15T05:49:01+00:00", "published_display": "15 Jun 2026 05:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Zasocitinib\u2019s Phase 3 Beat And New Shelf Filing Altering The Investment Case For Takeda Pharmaceutical (TSE:4502)?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-12T17:22:49+00:00", "published_display": "12 Jun 2026 17:22", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): oncology focus meets pricing headwinds", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOSS1EWGpYMnVNUjl3T2d6X1k5X20wVS1OQkdKdjd5YVlCemhEdnFrUWlSYkhQNGs4dWM2b2g3ZXVqRGpGYmZiZDFnT2Vob0NyeFp4U3ZlekhTQWVkWjNyYnltaDlibDUzSURENEtpaFllSExiVkhTMGRPWmFDVE84b0huV0pqLVpsSGNDQ1h0NU1VbXVsNWw2WTNtU0Npb29Gc2ZOencyX2ZjSDRHYktyTjdJVXhyZTl3c095RkNIaF9HT0ZVODBv?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-10T20:42:08+00:00", "published_display": "10 Jun 2026 20:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): New drug approvals and pipeline milestones in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPNTEzOXY5TGZHYU1UT3RTRDVGNk9BTHU3RTBPRVF1T1dUMmN4dUZGRFlFN25mbkpWSHBMWW9EeUFzdzBiWVZqYTVKdGVIZF8tbUNqR2xrWTJWQWhaREhUN3E0WFBndmhfdUdOeGV3SEFyeUYtSGgzNDRMa3hDeG9VbjhHUHg2OGJuc09PNFNmbmpOUUpNbEZ5Z0c1bEhlLVZLZTJFOC1CLUtMWGhuQUc3QWhETGkwYW9ta3Z6US00MA?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-09T20:33:11+00:00", "published_display": "09 Jun 2026 20:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Takeda Pharmaceutical (TSE:4502) Valuation As New CEO And Transformation Plan Take Shape", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (ADR) stock (US8740602052): shares fall in New York after shelf registration u", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQelg2dlM4WFpFSXB2bXk4elo1MFVtVmR1bzF3dWw4Y1BSYnA0d0tueVNRVVBGTTdrOTlabW5xZ012dmlsN0ZNU2d4cGRVamdWV21RU2hxdl9peWxHU2hvN0tfUU1IRjZuazB6a01PN1R6eDNncDZJZVluVjdXbk5hTmg4ZFBGRlFJOENsZ0NuZ0NRVXQzcC0zajBOa1BabzlLSlp2cFpaaFBVeGI2S1FYcUdVWGI3cVlRX005VDZnckU5LUZRdmc?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-01T23:02:13+00:00", "published_display": "01 Jun 2026 23:02", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (NYSE: TAK) files JPY 240B Japan shelf to support LTIP shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNNlBUbTV4eXhWRHhoSEgyN0RfMlViZUlaZ3N3T0dwT3YyN1B6Y3VaSVhtaUpoOVJaVDhab2tpazNlUV96VU5VLU5oaW5EUzVFQ0E1RzZLWm1aV1cxUUNQNHJkNVlveWVLb05SMXRlc0dIb0d0a19IQnVhS0NiR0kwWkpvZjZfd2haSWZobGpEVDBtNkF5Zk9ZS244TjlIY2I4OUxfMHhLR0FWOERNYzRQaEwyN0QySjZvMmJKZVdFU2I?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) Valuation Check As Short Term Weakness Meets Longer Term Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPZk1Na2F1bFYwUE9hR2FkVnhjaGZvbEVLUWZYblNlalFoNzE3ODBGREZJSEQ5dVo4MkhwMTQyemw0d0djaF9ZQ3BYVkZ6cldVWU9JLXRld0d3ay0yMTZneDA2Z2RhMmJpV3d3UmJDVE9reXRjVl9UV2F5elY4Wlk5TmJZNkdPN25WUjNpRUJkM2phb2VMWWlsYkwwUDJxVm9PUGV3VEhGY2szbm1FOWc?oc=5", "source_name": "Market source", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Workforce Cuts Reshape Costs While Valuation Signals Possible Upside", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-24T07:00:00+00:00", "published_display": "24 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): Japan sales and U.S. exposure stay in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOd2tpOTU0NGlwakVjWFpaMzFaMVh1V2NGWEVBSElvazZ6NXFBaTNEQnRicGFnWXMxSkt4M1BTVy1sbVlPX1pyOENPaXpUdmwyRkdRajhEZFNuM0ktZVEteUpMS0xrNlNSOWM1LTZaMm01b2h0M1NwQWVLX0w5dE5lYmdPcHhHQlU3aTdQS0c4QVZ4ZWhucU1zV0g0V1Rxb2dxb0hvdHFtMkNReGdPaW5LdjN2cFduV3dBakM0UFBaRUh5OWN4SUR3?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): oncology and rare disease focus after latest earnings up", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNQ1otS25EOU5IQUdySkVCbklDRzhLQ0VFRFd1UlRjdHhfVWFaZXIzdGsxckg0VGhQVHE2a0ZhYjNPcWZ0M1FocWFsTy05Q1JMSy0zVnhmZXVsMW1lZUJEdnRBLUZJLWJaLUNvNjU2WDY0OWFoc1h2cFpKbVVGVFNiNHpSRU4zUkl3eV9tSU9ZNEJkdFlyc0lYSWZjR0RKNG5xOERrMzd0Tm53bTBXS2NEMUNHdzZfRFdHNmZua1pSWTlfejQ?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): earnings in focus as investors weigh legal risks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPWUVuNjcwcFp5aUZkbWQ5eS11N3lrSWNfMlJpbHZLcVhhMk5iOWN4cldGUG5PY2NVcnFnaXZaSHhPS0VXa2F4aEJnTEw4LXlQZF80SWx6U3lZWGcwSENiWGE4dTI3eExHY0FiRl85cUdVNEcyYWlyWFlNeVpBRWtfYkhyUU42QmhYTTJ4UEU2Vnc5SkFnS21aWnpIbnV0bFdOMm0tNDRLOXMxX2tmbTVkUFlQRkowc1BhR1VZLTdQVEJJSEMxVVdOX1Nn?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Co Ltd stock (JP3730800003): earnings beat but softer EPS outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPSGFIWnpfUk1EMkVoRUpXTGtkT2JEaFQ1WlBlS196ZngxZHZaQ3hvdFAyQ1p3S0gyckR6aDFkU1ZnY3RpLTlkTG9Eb0VhNkRBb0g5SnVKMHZiZDhuN0JrajVuV3BNMTdUdm54VzkxcEpIN2U4Q1dOdTNVSkkzN3o0ZDhxcGJYOWVSek00NHRkakRuTF9ZMDhHMER5ai1ZUWNQVTdlaTdHRm5JblpXUDZPOEFseGpYSFBVMkZfLWZwRlJYZw?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): recent earnings and Rybelsus biosimilar plans in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPQU1SWUp6MEotLUZOck1uOU41SzNvQlNxM2UzN1JXSl9xcnRUM1lmYVBxTVE4Tm8wSTdKamdiMjlRcFQ1c21QellIbDdEcmZ6Yjd3Yy05dUZ0ZWp4M0QtQkRwWExYenRWZ2FhVGdUSzlUVjd1WTdyNXRRUXY3V3FSazVKcXhtRXIzai03TmVKUkU3bHJyeXFnMUhYOFZvSng0Wmptc2NTLURTdDJHSGtJT2pKRi1LOUZuOTRodlZVaDY1aWtYUEhF?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Company Limited Just Recorded A 8.6% EPS Beat: Here's What Analysts Are Forecasting Next", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): FY2026 profit surges 77.7%, but FY2027 guidance signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZFViNEw4ZGF4Q2lhTUNrREN6dnRFdENPMU1zWG1US0FfOGYwY0dBSFNkZmtYbHh5bDh3cEE2dXI5eUxVb0p4ZGtaRzluNEhpNGtDT09tNElFMEx3ZHI0cGkyYm9IRXRTV1dENkgyckJHdHlCUUpnQTg1YldHbjBSVkpvUDhJUXRGRnd3TVFTQUZtRlg4SllIbUtfeDFBYWQyUGRpS1lSQUlWa256LXFZVWllbHpQWktlXzJWOGU1QzVMZjg?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Ready to Resume Top-Line Growth With Refreshed Late-Stage Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNckF0ZTgxZTZ2ejFldFAydkpubF9MRGQzMWRLU0pTOFdzakxOelRiSFNVN2dPTjU1TVdoaHBCbmJMSEszUWNVUUxWdUlraDgxVlB2dGp5TXA1Z21WZmtFNGtkblVfaHBZOW5TM3VqMnhzX1pnNGZWYjNzSVR2dVFDZENyR2owRnF4MTI5MnRJZGR6dUh5RklRZHhKeXAxNWVIWlVyRmpwZ0hseXpnZU02aWdwanNpUHpDSTBfRHpZRHBwSUE?oc=5", "source_name": "Morningstar", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) Net Margin Improvement Tests Bearish Profitability Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): Q4 2026 earnings report released", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPY2VKNXkxeXktZ3lJeGFQY1h2M1V0R0FVdG1YUDRDemp6MFNvcjN6SGZfMGN5ZlpfaW45SWVIM0JUTU9fVktBdUl2bkJ3NU1qai1vaDFXTlFIbHFWeWFvSHEwZFY2Z201dTdRalhZck9jLUxnQkJVTmZXdHRqRVA1M0ltWGhZb01iSTVfWUF0Q2NVZ2J4bkZHbEZYT3prbXQtOXoxSUJMTXNhQnh2aEFqQnpaWmNYVlFMbE9pS3hhZE4?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) Valuation Check After Recent Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQeGp1cEpfNUx4ZjE5Ml9ONWFydUZqV0d4VTlvLWstc1U5YUZIcHFZcTAwbThPTHBxY2liWmVHbmtZVXZiVjl5NldjWUlROUY2WVJiTmJiQms1YzF1X1ZiNjd5NUtacTc1Yk0wc3VuM1g3NjMxdjZOblFfTGlzZWNKUDJiM1E0S1Z1YTZ4dDdJSkdhbjRESmNPOFp5RGJtbERkTTdDWTVWdkxUVTN0MVE?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Co Ltd stock (JP3730800003): Japan\u2019s largest pharma firm with strong US expo", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUF8wcDBCMUlxZ1hnNUMyXzlhUFBZVHZxRzM0dTl4dGpyaHZZU1hYZGtxbm15WkUzM2pqLTJTVnc0OXF0eVRMREx2aGQ0RjJpd2NjSV8yb0FvVUVpMjdmUHAtUllHX0pnUWlIZ2RtdnJRTmFSWEhhUVMxUTBNTW5USUdmakhPXzVhMzQ3bHo2bmJ1QVZHWEROUmljZUpoakItTVBTLVJYaGItV2FHZnJyM1VsRzBsR0M2QW1pa3gwTQ?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Japanese Stocks Amid Restructuring Drive?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQRkFWZ3o4c21ET2tVMzVGNDFhVS1OZnhIZU5uOEh5akxTT2JuV0ZvaEtLRl9DNHZBS1VwOVZWNlBnZEdYOVYta0ZnbmNmaUhoVDFURjJqT1QyZnBPWjJzenlmUnc5dGhyeW5NUWN0V1JyTE12WEtaVEluUm8wQ1FwLUdXZVFfU1JFTEhha0lmcXcxaF9hd19jcTZmSzY3N1F5cWlPal9jbGNIajNhbFQ4?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Takeda Pharmaceutical (TSE:4502) Pricing Look Compelling After Strong Multi\u2011Year Share Gains", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Takeda Pharmaceutical (TSE:4502) Valuation After Mixed Pipeline News On DNL593 And Zasocitinib", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQU1VkMlNwTmlsYkQ2X3lrWDRrQ2JQQU1jdERabHhCVHZhcVBVNGpnUHJ5dWdJVzVTMXZVSUVDaTJBUExQRkZOSS1ZWjNOTHBqMDM5Y3hGMTJES3AwdU9yU1FQejlRYmI2bGtpNHdVLVZPOEptWGF0d3VLM09CMzFvZTNoSzJHdjc4Z3RVZTZjRlJHQmliVE9xZGV0cGZydzhVRW5uMnlXUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Company Limited (TSE:4502) Goes Ex-Dividend Soon", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (NYSE: TAK) Japan Pharma chief details shares, RSUs and tax awards", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOMXBKQjVNeEcyeG11MHBkek51QjBoMHY4d3JzZWotckppck13OG5nU19mMGhvNFIzWElLcnl2OUlJN3M0eXhjdk1DaExPa251YXIza0FCd2FpblNnTXgybmR5VW84M1hlNXRMaTNZMldmYzJaZGhjY1Y2NjRLNHN5VmNCMEo3bW9GVDBLZ09qcmE2cXlvbTFDQTZxMnRpRWdpZzBydzlkRkZETl9LZVlYbTJCdHhIcGhwTWttdnBPaG54S1VJRWdCMW93?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Takeda Pharmaceutical (TSE:4502) Valuation After Strong Multi\u2011Period Shareholder Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQdzlod0dJcXdhdWhZd1k4V1JVY0QwWllGYU1ETVhxT1pmOXNsQjZjZzNycHdvZWNETjZqRElZdmJVc3ZpUktveFJRTmxyNUdkeDlxS0RpZF9xV1laVjNvZVlQWkpxX2hTaGFPQ1pUamFUWkczck9OckE0cmxUNVFmczNyWlNxMHBROU9wQmlBZw?oc=5", "source_name": "Market source", "published_at": "2026-03-15T07:00:00+00:00", "published_display": "15 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Takeda\u2019s Upgraded FY2025 Outlook And New PID Therapy Altering The Investment Case For Takeda (TSE:4502)?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNS0tIZE0xOGZsamFGRk1UM2VfSVE2RFMzU3RQcUxUVGUtUnhZV2kyeTFVTm1BU1R6THI2U3J0MnAwemp5dFAwVTQzWFZ5ODFHaThTTFlRVnNEeU15eG9KSTNDNm5fSXUxQlRxdHM1UE9uVmg2RHppWHk3bV9fY2RLT0JNX0p5VGc?oc=5", "source_name": "Market source", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPV2EwUkxKSVZNaEJLQ0o0NHFHdFZmQ29LTmt1NklBdnVFTHVueHZRTWRTSktZSk1BM1l6LS1sa1RTTXNnOEYtSUcyZ2JBU1V5a0pjRkRiOF9iN1hWNjRqOFpPalRTN0cydVNfbVM1NnB3MERnYmJWOFFKcmM4eE9aMzBabV9mTGgtUUN0dHpTWXM?oc=5", "source_name": "Market source", "published_at": "2026-01-31T08:00:00+00:00", "published_display": "31 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Takeda Pharmaceutical (TSE:4502) After Recent Pipeline Progress And Share Price Moves", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNc0RhajBSeDY4NDA1N2NqenA4cHBWRHE5Y3ZPWXNSdkplT3ZXNkJFRjZjLW1oX0FWNGZ1Z2VSWXpHYk9ISVpVMXozT1ZuZHRoNHFQaDhRNWYxTG4tUVlCdlJpOGM4RGZyRnhPMlAzMzFPUGVFYWdDUkxFMGNUbU5hQ1dJRnR6MlpiamNwSTdOUQ?oc=5", "source_name": "Market source", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TAK) Stock Price Today & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE5NcVB5QjBESXJYMGtyOWVLN2dqTEpKUWdkMjJCdzBxaHZtNU9yRmR2aXN2dkpmTHRSb0tnV0ZjNWVYU3RzSk9jR3M0blBNWXJESHBaWVdn?oc=5", "source_name": "Gotrade", "published_at": "2025-12-16T20:17:42+00:00", "published_display": "16 Dec 2025 20:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda: Lack Of Realistic Upside In Japanese Pharma (NYSE:TAK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPckc3aUR3TTRPMjVnQkFKRmxNRVZTQk5XdG41T0tZZnZnaDNERENKemd4dmNpRFhBU1dycV96MTQxVzBidkYyWTlSamVmSmhBQ3FGVGRkY0p2MndhT0Q4UXMwSThfNDBLWTJyWGd2akZZRUNHZGdFUFhoS3pqRGZ5cDFvVVQ5VmE2bHlTemIxcWM5VXhHMWc?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-12-11T08:00:00+00:00", "published_display": "11 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) Margin Miss Reinforces Bearish Narratives After \u00a5250.7B One-Off Loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNT2RJQUtlczNGaVVBX05ndzN5d0lxUFlFU0lOSzFGT0tpSDdreTE3TUZyUmtTN1JDM3VhaGEtbGNWVjNMZ3l4TV9aZzBURzYyOHNYTG14MjU4b3NfSzBMQm1uMjZTTko3Zml6OS1ObVVFSkZaQ3BIQ2lHRUJZZC1UWndXNi1YQzRBUHdr?oc=5", "source_name": "Market source", "published_at": "2025-11-01T07:00:00+00:00", "published_display": "01 Nov 2025 07:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Takeda Stock - analyst focus on pipeline and earnings outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOSklscmUxY3JSV1lQb1docmxYSWZleFl2OHRnWXpQdzNvWGRUZVZuVzhNSG8tV3J6LVpqU3l0ZWN5SkUwdFBWOXBIUXVnQ2k4cklhTzNlTHU2a3pJYTItYnZQYVltX1ozSWNmS0dYRzVqLTlscV9jTEFCMDJKYlY2TDRHU0ZSdlRzbkhQdC0zM2pEV0NndEpxbEVUQjNhUG9PRElzWEhYMmYyV0JYaVFKTWk1eUY5OXdNOGc?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-17T19:04:03+00:00", "published_display": "17 Jun 2026 19:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (TSE:4502) Unveils Phase 3 Wins In Narcolepsy And Psoriasis", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOOFZHOVZPOG1yeU9UTFdIWHFHYVhxcTkyZnVPem02T0QzZjNqZ19NcXhEQ2hQY0M4N2pieHhBbkxxY0c0Y2JhQWd4ODNSZ3JYanluNXBDM2RTNTRrRjVwZjZiXzd0STVMN0xueFlyTjJoa3FoYzRNSVloaFJlR2htaXRWSjNJWEZFc29wUmhWSFBubnly?oc=5", "source_name": "Market source", "published_at": "2026-06-16T18:13:39+00:00", "published_display": "16 Jun 2026 18:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Co Ltd (TSE:4502) Stock Price, Trades & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9GaWtTdlJmYTdXTDhCTUpta2NoNWhCVXFWNmRhUGNSbVJacjhNSzlIZkc0dzlWU2VlQnUtNWNKa1IyaTJ2X3gzbHpENmJnM0lJWWE1NTVnNDVzVThE?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-15T05:49:01+00:00", "published_display": "15 Jun 2026 05:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Zasocitinib\u2019s Phase 3 Beat And New Shelf Filing Altering The Investment Case For Takeda Pharmaceutical (TSE:4502)?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-12T17:22:49+00:00", "published_display": "12 Jun 2026 17:22", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): oncology focus meets pricing headwinds", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOSS1EWGpYMnVNUjl3T2d6X1k5X20wVS1OQkdKdjd5YVlCemhEdnFrUWlSYkhQNGs4dWM2b2g3ZXVqRGpGYmZiZDFnT2Vob0NyeFp4U3ZlekhTQWVkWjNyYnltaDlibDUzSURENEtpaFllSExiVkhTMGRPWmFDVE84b0huV0pqLVpsSGNDQ1h0NU1VbXVsNWw2WTNtU0Npb29Gc2ZOencyX2ZjSDRHYktyTjdJVXhyZTl3c095RkNIaF9HT0ZVODBv?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-10T20:42:08+00:00", "published_display": "10 Jun 2026 20:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): New drug approvals and pipeline milestones in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPNTEzOXY5TGZHYU1UT3RTRDVGNk9BTHU3RTBPRVF1T1dUMmN4dUZGRFlFN25mbkpWSHBMWW9EeUFzdzBiWVZqYTVKdGVIZF8tbUNqR2xrWTJWQWhaREhUN3E0WFBndmhfdUdOeGV3SEFyeUYtSGgzNDRMa3hDeG9VbjhHUHg2OGJuc09PNFNmbmpOUUpNbEZ5Z0c1bEhlLVZLZTJFOC1CLUtMWGhuQUc3QWhETGkwYW9ta3Z6US00MA?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-09T20:33:11+00:00", "published_display": "09 Jun 2026 20:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Takeda Pharmaceutical (TSE:4502) Valuation As New CEO And Transformation Plan Take Shape", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (ADR) stock (US8740602052): shares fall in New York after shelf registration u", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQelg2dlM4WFpFSXB2bXk4elo1MFVtVmR1bzF3dWw4Y1BSYnA0d0tueVNRVVBGTTdrOTlabW5xZ012dmlsN0ZNU2d4cGRVamdWV21RU2hxdl9peWxHU2hvN0tfUU1IRjZuazB6a01PN1R6eDNncDZJZVluVjdXbk5hTmg4ZFBGRlFJOENsZ0NuZ0NRVXQzcC0zajBOa1BabzlLSlp2cFpaaFBVeGI2S1FYcUdVWGI3cVlRX005VDZnckU5LUZRdmc?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-01T23:02:13+00:00", "published_display": "01 Jun 2026 23:02", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (NYSE: TAK) files JPY 240B Japan shelf to support LTIP shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNNlBUbTV4eXhWRHhoSEgyN0RfMlViZUlaZ3N3T0dwT3YyN1B6Y3VaSVhtaUpoOVJaVDhab2tpazNlUV96VU5VLU5oaW5EUzVFQ0E1RzZLWm1aV1cxUUNQNHJkNVlveWVLb05SMXRlc0dIb0d0a19IQnVhS0NiR0kwWkpvZjZfd2haSWZobGpEVDBtNkF5Zk9ZS244TjlIY2I4OUxfMHhLR0FWOERNYzRQaEwyN0QySjZvMmJKZVdFU2I?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) Valuation Check As Short Term Weakness Meets Longer Term Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPZk1Na2F1bFYwUE9hR2FkVnhjaGZvbEVLUWZYblNlalFoNzE3ODBGREZJSEQ5dVo4MkhwMTQyemw0d0djaF9ZQ3BYVkZ6cldVWU9JLXRld0d3ay0yMTZneDA2Z2RhMmJpV3d3UmJDVE9reXRjVl9UV2F5elY4Wlk5TmJZNkdPN25WUjNpRUJkM2phb2VMWWlsYkwwUDJxVm9PUGV3VEhGY2szbm1FOWc?oc=5", "source_name": "Market source", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Workforce Cuts Reshape Costs While Valuation Signals Possible Upside", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-24T07:00:00+00:00", "published_display": "24 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): Japan sales and U.S. exposure stay in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOd2tpOTU0NGlwakVjWFpaMzFaMVh1V2NGWEVBSElvazZ6NXFBaTNEQnRicGFnWXMxSkt4M1BTVy1sbVlPX1pyOENPaXpUdmwyRkdRajhEZFNuM0ktZVEteUpMS0xrNlNSOWM1LTZaMm01b2h0M1NwQWVLX0w5dE5lYmdPcHhHQlU3aTdQS0c4QVZ4ZWhucU1zV0g0V1Rxb2dxb0hvdHFtMkNReGdPaW5LdjN2cFduV3dBakM0UFBaRUh5OWN4SUR3?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): oncology and rare disease focus after latest earnings up", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNQ1otS25EOU5IQUdySkVCbklDRzhLQ0VFRFd1UlRjdHhfVWFaZXIzdGsxckg0VGhQVHE2a0ZhYjNPcWZ0M1FocWFsTy05Q1JMSy0zVnhmZXVsMW1lZUJEdnRBLUZJLWJaLUNvNjU2WDY0OWFoc1h2cFpKbVVGVFNiNHpSRU4zUkl3eV9tSU9ZNEJkdFlyc0lYSWZjR0RKNG5xOERrMzd0Tm53bTBXS2NEMUNHdzZfRFdHNmZua1pSWTlfejQ?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): earnings in focus as investors weigh legal risks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPWUVuNjcwcFp5aUZkbWQ5eS11N3lrSWNfMlJpbHZLcVhhMk5iOWN4cldGUG5PY2NVcnFnaXZaSHhPS0VXa2F4aEJnTEw4LXlQZF80SWx6U3lZWGcwSENiWGE4dTI3eExHY0FiRl85cUdVNEcyYWlyWFlNeVpBRWtfYkhyUU42QmhYTTJ4UEU2Vnc5SkFnS21aWnpIbnV0bFdOMm0tNDRLOXMxX2tmbTVkUFlQRkowc1BhR1VZLTdQVEJJSEMxVVdOX1Nn?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Co Ltd stock (JP3730800003): earnings beat but softer EPS outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPSGFIWnpfUk1EMkVoRUpXTGtkT2JEaFQ1WlBlS196ZngxZHZaQ3hvdFAyQ1p3S0gyckR6aDFkU1ZnY3RpLTlkTG9Eb0VhNkRBb0g5SnVKMHZiZDhuN0JrajVuV3BNMTdUdm54VzkxcEpIN2U4Q1dOdTNVSkkzN3o0ZDhxcGJYOWVSek00NHRkakRuTF9ZMDhHMER5ai1ZUWNQVTdlaTdHRm5JblpXUDZPOEFseGpYSFBVMkZfLWZwRlJYZw?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): recent earnings and Rybelsus biosimilar plans in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPQU1SWUp6MEotLUZOck1uOU41SzNvQlNxM2UzN1JXSl9xcnRUM1lmYVBxTVE4Tm8wSTdKamdiMjlRcFQ1c21QellIbDdEcmZ6Yjd3Yy05dUZ0ZWp4M0QtQkRwWExYenRWZ2FhVGdUSzlUVjd1WTdyNXRRUXY3V3FSazVKcXhtRXIzai03TmVKUkU3bHJyeXFnMUhYOFZvSng0Wmptc2NTLURTdDJHSGtJT2pKRi1LOUZuOTRodlZVaDY1aWtYUEhF?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Company Limited Just Recorded A 8.6% EPS Beat: Here's What Analysts Are Forecasting Next", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): FY2026 profit surges 77.7%, but FY2027 guidance signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZFViNEw4ZGF4Q2lhTUNrREN6dnRFdENPMU1zWG1US0FfOGYwY0dBSFNkZmtYbHh5bDh3cEE2dXI5eUxVb0p4ZGtaRzluNEhpNGtDT09tNElFMEx3ZHI0cGkyYm9IRXRTV1dENkgyckJHdHlCUUpnQTg1YldHbjBSVkpvUDhJUXRGRnd3TVFTQUZtRlg4SllIbUtfeDFBYWQyUGRpS1lSQUlWa256LXFZVWllbHpQWktlXzJWOGU1QzVMZjg?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Ready to Resume Top-Line Growth With Refreshed Late-Stage Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNckF0ZTgxZTZ2ejFldFAydkpubF9MRGQzMWRLU0pTOFdzakxOelRiSFNVN2dPTjU1TVdoaHBCbmJMSEszUWNVUUxWdUlraDgxVlB2dGp5TXA1Z21WZmtFNGtkblVfaHBZOW5TM3VqMnhzX1pnNGZWYjNzSVR2dVFDZENyR2owRnF4MTI5MnRJZGR6dUh5RklRZHhKeXAxNWVIWlVyRmpwZ0hseXpnZU02aWdwanNpUHpDSTBfRHpZRHBwSUE?oc=5", "source_name": "Morningstar", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) Net Margin Improvement Tests Bearish Profitability Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical stock (JP3730800003): Q4 2026 earnings report released", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPY2VKNXkxeXktZ3lJeGFQY1h2M1V0R0FVdG1YUDRDemp6MFNvcjN6SGZfMGN5ZlpfaW45SWVIM0JUTU9fVktBdUl2bkJ3NU1qai1vaDFXTlFIbHFWeWFvSHEwZFY2Z201dTdRalhZck9jLUxnQkJVTmZXdHRqRVA1M0ltWGhZb01iSTVfWUF0Q2NVZ2J4bkZHbEZYT3prbXQtOXoxSUJMTXNhQnh2aEFqQnpaWmNYVlFMbE9pS3hhZE4?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) Valuation Check After Recent Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQeGp1cEpfNUx4ZjE5Ml9ONWFydUZqV0d4VTlvLWstc1U5YUZIcHFZcTAwbThPTHBxY2liWmVHbmtZVXZiVjl5NldjWUlROUY2WVJiTmJiQms1YzF1X1ZiNjd5NUtacTc1Yk0wc3VuM1g3NjMxdjZOblFfTGlzZWNKUDJiM1E0S1Z1YTZ4dDdJSkdhbjRESmNPOFp5RGJtbERkTTdDWTVWdkxUVTN0MVE?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Co Ltd stock (JP3730800003): Japan\u2019s largest pharma firm with strong US expo", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUF8wcDBCMUlxZ1hnNUMyXzlhUFBZVHZxRzM0dTl4dGpyaHZZU1hYZGtxbm15WkUzM2pqLTJTVnc0OXF0eVRMREx2aGQ0RjJpd2NjSV8yb0FvVUVpMjdmUHAtUllHX0pnUWlIZ2RtdnJRTmFSWEhhUVMxUTBNTW5USUdmakhPXzVhMzQ3bHo2bmJ1QVZHWEROUmljZUpoakItTVBTLVJYaGItV2FHZnJyM1VsRzBsR0M2QW1pa3gwTQ?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Japanese Stocks Amid Restructuring Drive?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQRkFWZ3o4c21ET2tVMzVGNDFhVS1OZnhIZU5uOEh5akxTT2JuV0ZvaEtLRl9DNHZBS1VwOVZWNlBnZEdYOVYta0ZnbmNmaUhoVDFURjJqT1QyZnBPWjJzenlmUnc5dGhyeW5NUWN0V1JyTE12WEtaVEluUm8wQ1FwLUdXZVFfU1JFTEhha0lmcXcxaF9hd19jcTZmSzY3N1F5cWlPal9jbGNIajNhbFQ4?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Takeda Pharmaceutical (TSE:4502) Pricing Look Compelling After Strong Multi\u2011Year Share Gains", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Takeda Pharmaceutical (TSE:4502) Valuation After Mixed Pipeline News On DNL593 And Zasocitinib", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQU1VkMlNwTmlsYkQ2X3lrWDRrQ2JQQU1jdERabHhCVHZhcVBVNGpnUHJ5dWdJVzVTMXZVSUVDaTJBUExQRkZOSS1ZWjNOTHBqMDM5Y3hGMTJES3AwdU9yU1FQejlRYmI2bGtpNHdVLVZPOEptWGF0d3VLM09CMzFvZTNoSzJHdjc4Z3RVZTZjRlJHQmliVE9xZGV0cGZydzhVRW5uMnlXUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Company Limited (TSE:4502) Goes Ex-Dividend Soon", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (NYSE: TAK) Japan Pharma chief details shares, RSUs and tax awards", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOMXBKQjVNeEcyeG11MHBkek51QjBoMHY4d3JzZWotckppck13OG5nU19mMGhvNFIzWElLcnl2OUlJN3M0eXhjdk1DaExPa251YXIza0FCd2FpblNnTXgybmR5VW84M1hlNXRMaTNZMldmYzJaZGhjY1Y2NjRLNHN5VmNCMEo3bW9GVDBLZ09qcmE2cXlvbTFDQTZxMnRpRWdpZzBydzlkRkZETl9LZVlYbTJCdHhIcGhwTWttdnBPaG54S1VJRWdCMW93?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Takeda Pharmaceutical (TSE:4502) Valuation After Strong Multi\u2011Period Shareholder Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQdzlod0dJcXdhdWhZd1k4V1JVY0QwWllGYU1ETVhxT1pmOXNsQjZjZzNycHdvZWNETjZqRElZdmJVc3ZpUktveFJRTmxyNUdkeDlxS0RpZF9xV1laVjNvZVlQWkpxX2hTaGFPQ1pUamFUWkczck9OckE0cmxUNVFmczNyWlNxMHBROU9wQmlBZw?oc=5", "source_name": "Market source", "published_at": "2026-03-15T07:00:00+00:00", "published_display": "15 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Takeda\u2019s Upgraded FY2025 Outlook And New PID Therapy Altering The Investment Case For Takeda (TSE:4502)?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNS0tIZE0xOGZsamFGRk1UM2VfSVE2RFMzU3RQcUxUVGUtUnhZV2kyeTFVTm1BU1R6THI2U3J0MnAwemp5dFAwVTQzWFZ5ODFHaThTTFlRVnNEeU15eG9KSTNDNm5fSXUxQlRxdHM1UE9uVmg2RHppWHk3bV9fY2RLT0JNX0p5VGc?oc=5", "source_name": "Market source", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPV2EwUkxKSVZNaEJLQ0o0NHFHdFZmQ29LTmt1NklBdnVFTHVueHZRTWRTSktZSk1BM1l6LS1sa1RTTXNnOEYtSUcyZ2JBU1V5a0pjRkRiOF9iN1hWNjRqOFpPalRTN0cydVNfbVM1NnB3MERnYmJWOFFKcmM4eE9aMzBabV9mTGgtUUN0dHpTWXM?oc=5", "source_name": "Market source", "published_at": "2026-01-31T08:00:00+00:00", "published_display": "31 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Takeda Pharmaceutical (TSE:4502) After Recent Pipeline Progress And Share Price Moves", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNc0RhajBSeDY4NDA1N2NqenA4cHBWRHE5Y3ZPWXNSdkplT3ZXNkJFRjZjLW1oX0FWNGZ1Z2VSWXpHYk9ISVpVMXozT1ZuZHRoNHFQaDhRNWYxTG4tUVlCdlJpOGM4RGZyRnhPMlAzMzFPUGVFYWdDUkxFMGNUbU5hQ1dJRnR6MlpiamNwSTdOUQ?oc=5", "source_name": "Market source", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TAK) Stock Price Today & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE5NcVB5QjBESXJYMGtyOWVLN2dqTEpKUWdkMjJCdzBxaHZtNU9yRmR2aXN2dkpmTHRSb0tnV0ZjNWVYU3RzSk9jR3M0blBNWXJESHBaWVdn?oc=5", "source_name": "Gotrade", "published_at": "2025-12-16T20:17:42+00:00", "published_display": "16 Dec 2025 20:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda: Lack Of Realistic Upside In Japanese Pharma (NYSE:TAK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPckc3aUR3TTRPMjVnQkFKRmxNRVZTQk5XdG41T0tZZnZnaDNERENKemd4dmNpRFhBU1dycV96MTQxVzBidkYyWTlSamVmSmhBQ3FGVGRkY0p2MndhT0Q4UXMwSThfNDBLWTJyWGd2akZZRUNHZGdFUFhoS3pqRGZ5cDFvVVQ5VmE2bHlTemIxcWM5VXhHMWc?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-12-11T08:00:00+00:00", "published_display": "11 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) Margin Miss Reinforces Bearish Narratives After \u00a5250.7B One-Off Loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNT2RJQUtlczNGaVVBX05ndzN5d0lxUFlFU0lOSzFGT0tpSDdreTE3TUZyUmtTN1JDM3VhaGEtbGNWVjNMZ3l4TV9aZzBURzYyOHNYTG14MjU4b3NfSzBMQm1uMjZTTko3Zml6OS1ObVVFSkZaQ3BIQ2lHRUJZZC1UWndXNi1YQzRBUHdr?oc=5", "source_name": "Market source", "published_at": "2025-11-01T07:00:00+00:00", "published_display": "01 Nov 2025 07:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 35, "sentiment_summary": {"positive": 10, "negative": 4, "neutral": 21, "score": 53, "total": 35, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 13.9, "count": 24}, {"event": "earnings", "label": "Earnings", "weight": 5.5, "count": 10}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 10, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 5082.0, "latest_week": "2026-06-12", "one_week_move": 3.2, "four_week_move": -3.7, "twelve_week_move": -10.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.900962, "market_dynamics_buy_signal": false, "relative_strength": -18.199228, "fair_value_gap": 21.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 57.5271, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.2% over one week, -3.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "AD HOC NEWS", "count": 12}, {"label": "Market source", "count": 10}, {"label": "simplywall.st", "count": 7}, {"label": "Stock Titan", "count": 2}, {"label": "GuruFocus", "count": 1}, {"label": "Morningstar", "count": 1}, {"label": "Gotrade", "count": 1}, {"label": "Seeking Alpha", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 35}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 24}, {"label": "Earnings", "count": 10}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "35", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.2% over one week, -3.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Takeda Stock - analyst focus on pipeline and earnings outlook"}], "updated_at": "2026-06-19T14:55:30.105849+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}